Today: 25 June 2026

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Nvidia stock bounces in premarket as Amazon’s $200B AI spend stirs the trade; China chip licences in focus

Nvidia stock bounces in premarket as Amazon’s $200B AI spend stirs the trade; China chip licences in focus

Nvidia shares rose 2.7% in premarket trading Friday after the Nasdaq hit a two-month low. Amazon shares dropped 8% premarket following news its 2026 capital expenditures could reach $200 billion. Nvidia’s supply chain pushed back on AI bubble fears, while export policy talks with ByteDance remain unresolved. Investors await Nvidia’s Feb. 25 earnings and key U.S. economic data next week.
6 February 2026
·····
Doximity (DOCS) stock slips premarket after soft outlook, CFO medical leave, new $500 million buyback

Doximity (DOCS) stock slips premarket after soft outlook, CFO medical leave, new $500 million buyback

Doximity shares fell 5.4% to $33.32 premarket after the company forecast slower growth and said CFO Anna Bryson is on medical leave. Chief Accounting Officer Siddharth Sitaram was named interim finance head. The board approved a $500 million share buyback. Fiscal Q3 revenue rose 10% to $185.1 million, but Q4 guidance was below expectations.
6 February 2026
··
Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Coloplast A/S shares fell 7.82% to 495.35 crowns in Copenhagen after the company slashed its Kerecis growth forecast to 10% due to new U.S. Medicare reimbursement rules. Group revenue for the quarter was flat at 7,043 million crowns, with EBIT before special items down 3% to 1,850 million. Coloplast will phase out Kerecis Shield in Medicare outpatient care and shift focus to its MariGen range.
6 February 2026
·
Fortinet stock rises in premarket after earnings beat and upbeat 2026 outlook

Fortinet stock rises in premarket after earnings beat and upbeat 2026 outlook

Fortinet shares rose 2.8% to $81.11 premarket after quarterly earnings and revenue beat forecasts, with billings climbing to $2.37 billion. Adjusted earnings reached 81 cents per share on $1.91 billion revenue. The company projected first-quarter earnings below some estimates and approved a $1 billion increase to its share buyback program. Service revenue growth lagged, raising questions about renewal momentum.
6 February 2026
·
Kongsberg Gruppen ASA stock price jumps 14% as Q4 backlog hits record and €140m weapons order lands

Kongsberg Gruppen ASA stock price jumps 14% as Q4 backlog hits record and €140m weapons order lands

Kongsberg shares jumped 14% to 367.15 crowns after reporting record Q4 results and a €140 million weapons contract. The company set a regular 2.20 crowns and special 3.50 crowns dividend, pending April 13 approval. Order backlog reached 157.4 billion crowns. Kongsberg confirmed plans to spin off its maritime unit with a separate listing targeted for April 23.
6 February 2026
··
Nebius stock snaps higher in premarket after two-day slide as NBIS earnings near

Nebius stock snaps higher in premarket after two-day slide as NBIS earnings near

Nebius Group N.V. shares rose 4.8% to $77.41 in premarket trading Friday, rebounding after an 18% two-day drop amid a broader tech selloff. The Amsterdam-based AI cloud firm will report fourth-quarter and full-year 2025 results on Feb. 12. Investors are focused on Nebius’s spending plans and revenue outlook as scrutiny of capital expenditures in the sector intensifies.
6 February 2026
··
Lithium price slips again in China, dragging Albemarle and SQM shares lower before Wall Street opens

Lithium price slips again in China, dragging Albemarle and SQM shares lower before Wall Street opens

China’s battery-grade lithium carbonate price fell about 4% to 134,500 yuan per tonne, pressuring lithium stocks in U.S. premarket trading. Albemarle dropped 7.2%, SQM slipped 4%, and Lithium Americas lost 8.6%. Shanghai Metals Market said downstream stockpiling ahead of Lunar New Year is nearly complete. LME lithium hydroxide CIF slid 3.3% to $17,600 per tonne.
6 February 2026
··
Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health shares fell 2.3% to $12.22 in premarket trading Friday after a 5.4% drop Thursday, as investors reacted to Molina Healthcare’s profit warning and exit from Medicare Part D. Molina’s stock plunged nearly 35% after hours, dragging other managed-care stocks lower. Oscar reports earnings Feb. 10, with investors watching for updates on 2026 enrollment and claims.
6 February 2026
····
Gasoline prices today: RBOB futures tick up as U.S.-Iran talks put a floor under the market

Gasoline prices today: RBOB futures tick up as U.S.-Iran talks put a floor under the market

U.S. gasoline futures rose 0.43% to $1.9349 per gallon premarket Friday, while pump prices edged up to $2.90 a gallon, AAA reported. Gasoline inventories increased last week despite a drop in crude stocks, and refineries ran at 90.5% capacity. Oil prices were little changed as traders watched U.S.-Iran talks in Oman. Wholesale spot gasoline in New York Harbor climbed 1.1% to $2.16 a gallon.
6 February 2026
Heating Oil Price Today: ULSD slips in early trade as Iran talks, tight distillates stay in focus

Heating Oil Price Today: ULSD slips in early trade as Iran talks, tight distillates stay in focus

NYMEX heating oil futures fell 0.4% to $2.3830 a gallon in early New York trading Friday. U.S. distillate inventories dropped by 5.6 million barrels last week, hitting 127.4 million, according to the EIA. Traders are watching U.S.-Iran talks in Oman and upcoming inventory data for signals on supply risks. Brent crude edged up 7 cents to $67.62 a barrel.
6 February 2026
··
Amazon’s $200B AI Spend Shock Ripples Through Stocks Before Wall Street Opens

Amazon’s $200B AI Spend Shock Ripples Through Stocks Before Wall Street Opens

Amazon shares fell 4.5% to $222.69 premarket Friday after the company projected $200 billion in 2026 capital spending, up from $131 billion for 2025, fueling investor concerns over AI-related costs. Microsoft dropped 4.9%, AMD 3.9%, and Super Micro Computer 8.6%. Alphabet forecast $175–185 billion in 2026 capex, more than double its 2025 plan. Broadcom rose 0.8%.
6 February 2026
··
US economic calendar today: No jobs report, but consumer sentiment and Fed events loom as stocks slide

US economic calendar today: No jobs report, but consumer sentiment and Fed events loom as stocks slide

SPDR S&P 500 ETF fell 1.2% and QQQ dropped 1.4% in premarket trading Friday as the January U.S. jobs report was delayed by a government shutdown. The Bureau of Labor Statistics rescheduled the report for Feb. 11. Announced layoffs surged 205% in January, according to Challenger, Gray & Christmas. Amazon shares slid 15% after projecting higher capital spending.
6 February 2026
···
1 … 70 71 72 73 74 … 595

Stock Market Today

  • BioMarin Pharmaceutical Q1 Earnings Compared to Therapeutics Peers
    June 25, 2026, 12:26 PM EDT. BioMarin Pharmaceutical (NASDAQ:BMRN) posted $766.2 million in Q1 revenue, a 2.8% increase year-on-year but slightly below analysts' expectations by 1.3%. Despite missing EPS estimates, BioMarin raised full-year guidance the most among 11 tracked therapeutics stocks, reflecting confidence fueled by its acquisition of Amicus Therapeutics and portfolio expansion. The therapeutics sector saw a 14.5% revenue beat against consensus, driven by advances in precision medicine and rare disease treatments. Moderna (NASDAQ:MRNA) led Q1 gains with a 260% revenue surge, outperforming expectations by 56%. BioMarin's shares advanced 3.8% post-report, trading at $57.57, marking resilience amid market headwinds including drug pricing scrutiny and regulatory uncertainties.

Latest News

MARA Stock Drops After Monday’s Jump, Bitcoin and Nasdaq Weakness Pressure AI Pivot Trade

MARA Holdings dips after AI bull call runs into share plan math

25 June 2026
MARA Holdings (NASDAQ:MARA) dropped 3.0% to $13.585 despite a bullish $24 target from Citizens, as investors weighed a shareholder-approved 18 million share increase to its equity plan—about 4.7% dilution risk—amid ongoing bitcoin exposure and a $1.26 billion Q1 net loss driven by crypto price swings.
Strategy (NASDAQ:MSTR) drops as STRC dividend pulls bitcoin funding

Strategy (NASDAQ:MSTR) drops as STRC dividend pulls bitcoin funding

25 June 2026
Strategy Inc (MSTR) stock fell 5.7% after raising $335.5 million in new shares but using only $34.9 million to buy bitcoin, with most funds boosting its USD reserve to $1.4 billion—enough to cover 14 months of STRC preferred dividends, as STRC traded 21% below par amid market focus on cash reserves over bitcoin buys.
Go toTop